The Regions We Work In
Getting in Touch
Primary Care Research Network
East Midlands & South Yorkshire
Co-ordinating Centre
6th Floor, St John's House
30 East Street
Leicester LE1 6NB
E. judith.martin@emsy.nhs.uk
T. 0116 295 4080
F. 0116 295 4177
Studies A-Z > O > Ondansetron for IBS-D
Ondansetron for the treatment of IBS with diarrhoea (IBS-D): Identifying the responder
IBS is a common problem, with often distressing symptoms that can result in a reduced quality of life. This is a two-centre randomised double blind placebo controlled crossover trial of Ondansetron in IBS-D. The aim is to identify clinical, laboratory and MRI scan features that will predict response in clinical practice. The primary outcome measure is a change in average stool consistency in the last two weeks of treatment of Ondansetron versus placebo.